[go: up one dir, main page]

MX2010004265A - Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo. - Google Patents

Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo.

Info

Publication number
MX2010004265A
MX2010004265A MX2010004265A MX2010004265A MX2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A MX 2010004265 A MX2010004265 A MX 2010004265A
Authority
MX
Mexico
Prior art keywords
active ingredient
administering
composition
making
same
Prior art date
Application number
MX2010004265A
Other languages
English (en)
Inventor
Elyse Dussia
Benjamin Thomas
Robert S Davidson
Maurice E Durschlag
Gary S Kehoe
Original Assignee
Innozen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innozen Inc filed Critical Innozen Inc
Publication of MX2010004265A publication Critical patent/MX2010004265A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

En la presente se proporcionan composiciones para administrar oralmente o en forma transmucosal un ingrediente activo, que tienen una capa de película, un revestimiento aplicado en por lo menos un lado de la capa de película, y un ingrediente activo en la capa de película, en revestimiento, o en ambas capas; en ciertas modalidades la composición también incluye un compuesto efervescente.
MX2010004265A 2007-10-19 2008-10-17 Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo. MX2010004265A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98138907P 2007-10-19 2007-10-19
PCT/US2008/080362 WO2009052421A1 (en) 2007-10-19 2008-10-17 Composition for administering an active ingredient and method for making and using the same

Publications (1)

Publication Number Publication Date
MX2010004265A true MX2010004265A (es) 2010-07-28

Family

ID=40567804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004265A MX2010004265A (es) 2007-10-19 2008-10-17 Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo.

Country Status (4)

Country Link
EP (1) EP2214478A1 (es)
CA (1) CA2702614A1 (es)
MX (1) MX2010004265A (es)
WO (1) WO2009052421A1 (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8731673B2 (en) 2007-02-26 2014-05-20 Sapiens Steering Brain Stimulation B.V. Neural interface system
CA2749564C (en) * 2009-01-13 2016-11-15 Monosolrx Llc Unit assembly for multiple film dosages, apparatus, and methods
US20100291160A1 (en) * 2009-05-13 2010-11-18 Carver David R Pharmaceutical system for trans-membrane delivery
HUE028121T2 (en) 2009-06-12 2016-11-28 Cynapsus Therapeutics Inc Sublingual apomorphine
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US20180110724A1 (en) * 2009-12-08 2018-04-26 Intelgenx Corp. Film dosage form with multimodal and particle size distributions
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
WO2012053006A2 (en) 2010-10-18 2012-04-26 Panacea Biotec Ltd Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
HUE049349T2 (hu) 2010-12-16 2020-09-28 Sunovion Pharmaceuticals Inc Szublingvális filmek
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10687975B2 (en) * 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US10562281B2 (en) 2011-08-02 2020-02-18 Kimberly-Clark Worldwide, Inc. Cooling signal device for use in an absorbent article
EP2594257A1 (en) * 2011-11-17 2013-05-22 Labtec GmbH Orodispersible films for the manufacturing of individualised medicine or for large scale production
WO2013023775A1 (en) * 2011-08-12 2013-02-21 Labtec Gmbh Orodispersible films for the manufacturing of individualised medicine or for large scale production
WO2014092661A1 (en) * 2012-01-18 2014-06-19 Mahmut Bilgic Particulate formulations of tadalafil in effervescent form
US20150132410A1 (en) * 2013-11-14 2015-05-14 Michael M. Jacobs Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
BR112017020307B1 (pt) 2015-03-26 2023-11-07 Jacqueline M. Iversen Usos de uma combinação de naproxeno e fexofenadina
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US9855227B2 (en) 2015-12-18 2018-01-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
FR3058871A1 (fr) * 2016-11-18 2018-05-25 Adnane Remmal Composition stable solide a base de compose aromatique et utilisations
US12150967B2 (en) 2018-08-18 2024-11-26 Seed Health, Inc. Methods and compositions for honey bee health
US20200281889A1 (en) * 2019-03-07 2020-09-10 Terpene Therapeutics Inc. Edible Film Comprising Adjacent Conjoined Strips
EP3989909A1 (en) 2019-06-27 2022-05-04 Sunovion Pharmaceuticals Inc. Child-resistant dispensers for thin strip medications
WO2021100063A1 (en) 2019-11-22 2021-05-27 Wockhardt Limited Oral film composition comprising levothyroxine
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
WO2021242913A1 (en) * 2020-05-26 2021-12-02 Strategic Drug Solutions, Inc. Formulations and methods for treating erectile dysfunction
DE102021100718A1 (de) 2021-01-15 2022-07-21 Lts Lohmann Therapie-Systeme Ag. Aufgestreute Rückschicht
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment
WO2025106972A1 (en) * 2023-11-17 2025-05-22 Teeth Tabs PLLC Tableted effervescing dental treatment composition, and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010006677A1 (en) * 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
US8765167B2 (en) * 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20040247649A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films
MXPA05005243A (es) * 2002-11-14 2006-03-10 Innozen Inc Pelicula comestible para el alivio de la tos o sontomas relacionados con la faringitis.
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
AU2006242246A1 (en) * 2005-05-03 2006-11-09 Innozen, Inc. Edible film for transmucosal delivery of nutritional supplements

Also Published As

Publication number Publication date
EP2214478A1 (en) 2010-08-11
WO2009052421A1 (en) 2009-04-23
CA2702614A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
MX2010004265A (es) Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo.
MX2009007254A (es) Composiciones de tableta en tableta.
MY152985A (en) Cosmetic or pharmaceutical composition, to be applied topically
WO2007081835A3 (en) Modulators of hypoxia inducible factor-1 and related uses
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
WO2006023444A3 (en) Anti-adhesion barrier
WO2006058234A3 (en) Medical devices with highly flexible coated hypotube
TW200745413A (en) Method of forming a vapor impermeable, repulpable coating for a cellulosic substrate and a coating composition for the same
WO2008092006A3 (en) Antimicrobial compositions
MY158687A (en) Micro-needle device and preparation method
WO2009105294A3 (en) Topical compositions and methods for whitening skin
WO2007064885A3 (en) Oral care compositions, methods, devices and systems
MY162513A (en) Layered film compositions, packages prepared therefrom, and methods of use
WO2008002529A3 (en) Orally disintegrating layered compositions
MY158832A (en) Multilayer films for delivery of flavor
WO2008085570A3 (en) Flux formulations
WO2007130841A3 (en) Oral compositions comprising siloxane polymers
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
AR061545A1 (es) Tableta que contiene candesartan cilexetilo
EP1846420A4 (en) COMPOSITION FOR THE PREPARATION OF PRISM LAYERS AND PRISM FILM PRODUCED BY THEIR USE
WO2010019611A3 (en) Bridged polycyclic compound based compositions for topical and oral applications
MX2023012535A (es) Composicion oral efervescente.
WO2007132296A3 (en) Multilayer tablet
WO2008142569A3 (en) Topical compositions containing magaldrate
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal